Achieve Life Sciences (ACHV) PT Lowered to $18 at Oppenheimer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts ACHV Hot Sheet
Price: $6.61 --0%
Rating Summary:
14 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 13 | New: 3
Rating Summary:
14 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 13 | New: 3
Join SI Premium – FREE
Oppenheimer analyst Francois Brisebois lowered the price target on Achieve Life Sciences (NASDAQ: ACHV) to $18.00 (from $21.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Achieve Life Sciences Announces Granting of New Hire Inducement Awards
- Upwork Inc. (UPWK) PT Raised to $13 at Needham
- Marico Ltd (MRCO:IN) PT Raised to INR900 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
